On 2025-05-08, Royalty Pharma PLC (RPRX) announced earnings per share of $1.06 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $0.99.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $1.10 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $0.99 | $1.06 |
| 2025-02-11 | 2024-12-31 | $1.09 | $1.15 |
| 2024-11-06 | 2024-09-30 | $0.95 | $1.04 |
| 2024-08-08 | 2024-06-30 | $0.95 | $0.96 |
| 2024-05-09 | 2024-03-31 | $0.96 | $0.98 |
| 2024-02-15 | 2023-12-31 | $1.03 | $1.15 |
| 2023-11-08 | 2023-09-30 | $0.81 | $0.79 |
| 2023-08-08 | 2023-06-30 | $0.83 | $0.85 |
| 2023-05-09 | 2023-03-31 | $1.32 | $1.60 |
| 2023-02-15 | 2022-12-31 | $1.56 | $1.56 |
| 2022-11-08 | 2022-09-30 | $0.71 | $0.73 |
| 2022-08-04 | 2022-06-30 | $0.78 | $0.79 |
| 2022-05-05 | 2022-03-31 | $0.72 | $0.61 |
| 2022-02-15 | 2021-12-31 | $0.79 | $0.80 |
| 2021-11-10 | 2021-09-30 | $0.69 | $0.73 |
| 2021-08-11 | 2021-06-30 | $0.70 | $0.71 |
| 2021-05-11 | 2021-03-31 | $0.65 | $0.67 |
| 2021-02-17 | 2020-12-31 | $0.70 | $0.28 |
| 2020-11-10 | 2020-09-30 | $0.59 | $0.48 |
| 2020-08-12 | 2020-06-30 | $0.61 | $0.73 |